The outcome of next-generation sequencing showed a low tumor mutational burden (11.5 mut/Mb), and mutations in genes F-box and WD repeat domain containing 7 (FBXW7), PKHD1, and FAT atypical cadherin 1 (FAT1). Here, FBXW7 is linked to neoplasm.